Deciphering intratumoral heterogeneity using integrated clonal tracking and single-cell transcriptome analyses
Abstract Cellular heterogeneity is a major cause of treatment resistance in cancer. Despite recent advances in single-cell genomic and transcriptomic sequencing, it remains difficult to